Endo International plc
USD0.37
+0.01 (+1.99%)
CEO
Blaise Coleman
IPO Date
2014-03-03
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$0.39
Prev. Close
$0.37
Day Low
$0.37
Day High
$0.40
Volume
20.61M
| 9.1 |
| 31 Dec 2019 | FY | 46.2% | -14.5% | 48.8% | -4.5% | -9.70 | 1.77 | -2.5 |
| 31 Dec 2018 | FY | 44.6% | -35.0% | 207.0% | -10.2% | -16.57 | 1.20 | -1.6 |
| 31 Dec 2017 | FY | 35.8% | -58.7% | -419.8% | -17.5% | 17.07 | 1.02 | -0.8 |
| 31 Dec 2016 | FY | 34.3% | -83.5% | -123.9% | -23.4% | 3.06 | 0.98 | -1.1 |
| 31 Dec 2015 | FY | 36.5% | -45.7% | -25.1% | -7.7% | 1.44 | 1.00 | -9.1 |
| 31 Dec 2014 | FY | 51.3% | -25.1% | -30.4% | -6.6% | 1.84 | 1.07 | -15.4 |
| 31 Dec 2013 | FY | 60.3% | -26.2% | -130.3% | -10.4% | 7.11 | 1.68 | -12.9 |
| 31 Dec 2012 | FY | 58.3% | -24.5% | -69.0% | -11.3% | 2.96 | 1.14 | -11.5 |
| -2.1 |
| 31 Dec 2021 | Q4 | 60.6% | -70.5% | 44.7% | -6.3% | -6.50 | 1.67 | -0.4 |
| 30 Sept 2021 | Q3 | 62.9% | -10.0% | 11.2% | -0.8% | -12.05 | 1.77 | -2.5 |
| 30 Jun 2021 | Q2 | 55.4% | -2.2% | 2.5% | -0.2% | -13.48 | 1.82 | -17.6 |
| 31 Mar 2021 | Q1 | 57.5% | 5.8% | -6.9% | 0.4% | -13.90 | 1.79 | 10.3 |
| 31 Dec 2020 | Q4 | 51.4% | 15.7% | -18.4% | 1.3% | -12.85 | 1.92 | 3.5 |
| 30 Sept 2020 | Q3 | 45.2% | -12.0% | 9.7% | -0.8% | -10.65 | 2.17 | -2.5 |
| 30 Jun 2020 | Q2 | 51.1% | 1.5% | -1.5% | 0.1% | -11.68 | 2.20 | 18.7 |
| 31 Mar 2020 | Q1 | 52.6% | 15.8% | -17.6% | 1.4% | -11.39 | 2.03 | 1.6 |